NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $827,679 | -1.3% | 8,126 | -2.2% | 0.12% | +10.1% |
Q2 2023 | $838,360 | -13.3% | 8,308 | -21.0% | 0.11% | -17.4% |
Q1 2023 | $967,477 | +1.3% | 10,516 | -0.1% | 0.13% | -3.6% |
Q4 2022 | $954,940 | +12.1% | 10,526 | -6.1% | 0.14% | -2.1% |
Q3 2022 | $852,000 | -12.8% | 11,204 | +4.7% | 0.14% | -15.7% |
Q2 2022 | $977,000 | -11.3% | 10,704 | -14.7% | 0.17% | -0.6% |
Q1 2022 | $1,101,000 | -1.3% | 12,543 | -1.6% | 0.17% | -0.6% |
Q4 2021 | $1,115,000 | +21.9% | 12,745 | +13.9% | 0.17% | +7.7% |
Q3 2021 | $915,000 | -6.3% | 11,190 | +4.5% | 0.16% | -5.5% |
Q2 2021 | $977,000 | +16.9% | 10,704 | +9.4% | 0.16% | +10.7% |
Q1 2021 | $836,000 | -1.9% | 9,781 | +8.4% | 0.15% | -6.9% |
Q4 2020 | $852,000 | +10.8% | 9,027 | +2.0% | 0.16% | +1.9% |
Q3 2020 | $769,000 | +6.2% | 8,847 | +6.7% | 0.16% | -3.1% |
Q2 2020 | $724,000 | -1.5% | 8,290 | -6.9% | 0.16% | -14.3% |
Q1 2020 | $735,000 | -14.7% | 8,909 | -2.1% | 0.19% | +1.1% |
Q4 2019 | $862,000 | – | 9,099 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
Elefante Mark B | 4,579 | $333,000 | 4.02% |
COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |